High efficient adenoviral-mediated VEGF and Ang-1 gene delivery into osteogenically differentiated human mesenchymal stem cells

Microvascular Research

Volumn 75, Issue 1, 2008, Pages 83-90

  Klöpper, Jonas ^a   Lindenmaier, Werner ^b   Fiedler, Ulrike ^c   Mehlhorn, Alexander ^a   Stark, G Björn ^a   Finkenzeller, Günter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c TUMOR BIOLOGY CENTER   (Germany)

Author keywords

Adenovirus; Angiopoietin 1; Gene transfer; HUVEC; Mesenchymal stem cell; Osteogenic differentiation; Tissue engineering; VEGF

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 1; GROWTH FACTOR; VASCULOTROPIN;

ADENOVIRUS; ADULT; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; BONE TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEOVASCULARIZATION (PATHOLOGY); NORMAL HUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPROUTING; TISSUE ENGINEERING; UMBILICAL VEIN; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ADULT STEM CELLS; ANGIOPOIETIN-1; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; GENETIC VECTORS; HUMANS; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OSTEOGENESIS; SPHEROIDS, CELLULAR; TIME FACTORS; TISSUE ENGINEERING; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADENOVIRIDAE;

EID: 37249069103     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2007.04.010     Document Type: Article

References (38)

1. Arsic N., Zentilin L., Zacchigna S., Santoro D., Stanta G., Salvi A., Sinagra G., and Giacca M. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol. Ther. 7 (2003) 450-459
2. Asahara T., Chen D., Tsurumi Y., Kearney M., Rossow S., Passeri J., Symes J.F., and Isner J.M. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 94 (1996) 3291-3302
3. Baumgartner I., Pieczek A., Manor O., Blair R., Kearney M., Walsh K., and Isner J.M. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97 (1998) 1114-1121
4. Bauters C., Asahara T., Zheng L.P., Takeshita S., Bunting S., Ferrara N., Symes J.F., and Isner J.M. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 267 (1994) H1263-H1271
5. Carmeliet P., and Collen D. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr. Top. Microbiol. Immunol. 237 (1999) 133-158
6. DeBusk L.M., Hallahan D.E., and Lin P.C. Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Exp. Cell Res. 298 (2004) 167-177
7. Dvorak H.F., Nagy J.A., Feng D., Brown L.F., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237 (1999) 97-132
8. Fiedler U., Krissl T., Koidl S., Weiss C., Koblizek T., Deutsch U., Martiny-Baron G., Marme D., and Augustin H.G. Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J. Biol. Chem. 278 (2003) 1721-1727
9. Gamble J.R., Drew J., Trezise L., et al. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ. Res. 87 (2000) 603-607
10. Gerber H.P., McMurtrey A., Kowalski J., Yan M., Keyt B.A., Dixit V., and Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273 (1998) 30336-30343
11. Griffith C.K., Miller C., Sainson R.C., Calvert J.W., Jeon N.L., Hughes C.C., and George S.C. Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng. 11 (2005) 257-267
12. Haspel H.C., Scicli G.M., McMahon G., and Scicli G.M. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Microvasc. Res. 63 (2002) 304-315
13. Hayes A.J., Huang W.Q., Mallah J., Yang D., Lippman M.E., and Li L.Y. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc. Res. 58 (1999) 224-237
14. Henry T.D., Rocha-Singh K., Isner J.M., Kereiakes D.J., Giordano F.J., Simons M., Losordo D.W., Hendel R.C., Bonow R.O., Eppler S.M., Zioncheck T.F., Holmgren E.B., and McCluskey E.R. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am. Heart J. 42 (2001) 872-880
15. Jager M., Feser T., Denck H., and Krauspe R. Proliferation and osteogenic differentiation of mesenchymal stem cells cultured onto three different polymers in vitro. Ann. Biomed. Eng. 33 (2005) 1319-1332
16. Kanda S., Miyata Y., Mochizuki Y., Matsuyama T., and Kanetake H. Angiopoietin 1 is mitogenic for cultured endothelial cells. Cancer Res. 65 (2005) 6820-6827
17. Khan T.A., Sellke F.W., and Laham R.J. Therapeutic angiogenesis: protein-based therapy for coronary artery disease. Expert Opin. Pharmacother. 4 (2003) 219-226
18. Kim I., Kim H.G., So J.N., Kim J.H., Kwak H.J., and Koh G.Y. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ. Res. 86 (2000) 24-29
19. Kim I., Kim H.G., Moon S.O., Chae S.W., So J.N., Koh K.N., Ahn B.C., and Koh G.Y. Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ. Res. 86 (2000) 952-959
20. Koblizek T.I., Weiss C., Yancopoulos G.D., Deutsch U., and Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8 (1998) 529-532
21. Korff T., and Augustin H.G. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J. Cell Biol. 143 (1998) 1341-1352
22. Marion N.W., and Mao J.J. Mesenchymal stem cells and tissue engineering. Methods Enzymol. 420 (2006) 339-361
23. Mayer H., Bertram H., Lindenmaier W., Korff T., Weber H., and Weich H. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J. Cell Biochem. 95 (2005) 827-839
24. Medhurst A.D., Harrison D.C., Read S.J., Campbell C.A., Robbins M.J., and Pangalos M.N. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J. Neurosci. Methods 98 (2000) 9-20
25. Mehlhorn A.T., Schmal H., Kaiser S., Lepski G., Finkenzeller G., Stark G.B., and Sudkamp N.P. Mesenchymal stem cells maintain TGF-beta-mediated chondrogenic phenotype in alginate bead culture. Tissue Eng. 12 (2006) 1393-1403
26. Papapetropoulos A., Fulton D., Mahboubi K., Kalb R.G., O'Connor D.S., Li F., Altieri D.C., and Sessa W.C. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem. 275 (2000) 9102-9105
27. Rodriguez J.P., Gonzalez M., Rios S., and Cambiazo V. Cytoskeletal organization of human mesenchymal stem cells (MSC) changes during their osteogenic differentiation. J. Cell Biochem. 93 (2004) 721-731
28. Rosinberg A., Khan T.A., Sellke F.W., and Laham R.J. Therapeutic angiogenesis for myocardial ischemia. Expert Rev. Cardiovasc. Ther. 2 (2004) 271-283
29. Schumacher B., Pecher P., von Specht B.U., and Stegmann T. Induction of neo-angiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 97 (1998) 645-650
30. Suzuki K., Murtuza B., Smolenski R.T., Sammut I.A., Suzuki N., Kaneda Y., and Yacoub MH. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104 12 Suppl. 1 (2001) I207-I212
31. Takahashi T., Ueno H., and Shibuya M. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18 (1999) 2221-2230
32. Takeshita S., Isshiki T., Ochiai M., Eto K., Mori H., Tanaka E., Umetani K., and Sato T. Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 98 (1998) 1261-1263
33. Thurston G., Suri C., Smith K., et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 (1999) 2511-2514
34. Thurston G., Rudge J.S., Ioffe E., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6 (2000) 460-463
35. Wenger A., Stahl A., Weber H., Finkenzeller G., Augustin H.G., Stark G.B., and Kneser U. Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng. 10 (2004) 1536-1547
36. Yang J., Zhou W., Zheng W., Ma Y., Lin L., Tang T., Liu J., Yu J., Zhou X., and Hu J. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 107 (2007) 17-29
37. Ye L., Haider H.K.h., Jiang S., Ge R., Law P.K., and Sim E.K. High efficiency transduction of human VEGF165 into human skeletal myoblasts: in vitro studies. Exp. Mol. Med. 35 (2003) 412-420
38. Young D.M., Greulich K.M., and Weier H.G. Species-specific in situ hybridization with fluorochrome-labeled DNA probes to study vascularization of human skin grafts on athymic mice. J. Burn Care Rehabil. 17 (1996) 305-310